New insulin study aims for better blood sugar control
NCT ID NCT05002933
Summary
This study tested how well and safely a long-acting insulin called glargine U300 worked for Chinese adults whose type 2 diabetes was not well controlled. It involved 570 participants who either started this insulin for the first time or switched to it from another insulin. Researchers measured changes in blood sugar levels over 6 months of treatment, followed by 3 more months of observation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Sites
China, China
Conditions
Explore the condition pages connected to this study.